Searching…
Find the latest Sarepta Therapeutics, Inc. (SRPT) stock quote, history, news and other vital information to help you with your stock trading and investing.
See the company profile for Sarepta Therapeutics, Inc. (SRPT) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ...
Discover historical prices for SRPT stock on Yahoo Finance. View daily, weekly or monthly format back to when Sarepta Therapeutics, Inc. stock was issued.
View the basic SRPT option chain and compare options of Sarepta Therapeutics, Inc. on Yahoo Finance.
Jun 16, 2025 · Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 44.4% in the afternoon session after the company reported a second death linked to its Duchenne muscular dystrophy gene therapy ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Feb 14, 2026 · Sarepta Therapeutics (SRPT) has drawn attention after a period where the share price shows mixed short term performance, including a 2.2% gain over the past day but a 22% decline over the past ...
Jul 30, 2025 · Sarepta Therapeutics (SRPT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
May 7, 2025 · Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 20.5% in the afternoon session after the company reported weak first quarter 2025 results which featured drastically lowered full ...
Sep 3, 2025 · "Sarepta Therapeutics, Inc. (NASDAQ:SRPT) develops RNA-targeted medicines and gene therapies for rare neuromuscular diseases. The company reported quarterly revenue that exceeded expectations, but ...
